Goh Khoon Seng, Chief Executive Officer Osteopore
Over his 30-year career in the medical device industry, Mr Goh has always been passionate about improving patients’ lives by developing and bringing technological advancements to medical practitioners. His experience spans both start-ups and global multinational corporations, with over 20 years in mid and senior management with Medtronic plc (the world's largest medical device company) and Edwards Lifesciences before joining Osteopore as a director in 2015.
Osteopore bolsters Scientific & Clinical Advisory Panel
Osteopore Limited (ASX: OSX), a global leader in the manufacture of innovative regenerative...
2 minute read
What are bioresorbable implants and why Osteopore is committed to them
At Osteopore, we are global leaders in the design and manufacture of regenerative biomimetic...
1 minute read
3D Printing Enables Microarchitecture Required in Biomimetic Scaffolds
The science of tissue engineering and regenerative medicine aims to provide surgeons with a...
1 minute read
Regrowing Damaged Body Parts: How One Australian-listed Company is Making it Accessible
Osteopore, an Australian and...
1 minute read
The Suzhou Industrial Park and Collaboration
At Osteopore, one of our guiding principles is the value of collaboration. We believe that it is...
1 minute read
In-vitro vs in-situ tissue engineering. What are the differences?
There is a lot of hype around in-vitro tissue engineering, because ‘growing an organ in a lab’...
2 minute read